Form 4 for RARE Ultragenyx Pharmaceutical Inc.
Accepted 2026-05-18 18:38:30 ET · period of report 2026-05-14 · accession 0001796536-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-18 18:38 | 2026-05-14 | RARE | Sanders Corazon (Corsee) D. | Dir | A - Grant | $0.00 | +7,751 | 23.1K | +51% | $0 |
| D | 2026-05-18 18:38 | 2026-05-14 | RARE | Sanders Corazon (Corsee) D. | Dir | A - Grant | $0.00 | +14.1K | 14.1K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-14 | A | A | 7,751 | $0.00 | 23,095 | D | — | — | (F1) Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027. |
| 2 | Derivative | Stock Option (Right to Buy) | 2026-05-14 | A | A | 14,058 | $0.00 | 14,058 | D | $25.80 · — to 2036-05-14 | 14,058 Common Stock | (F2) The option shall vest in full on the earlier of (i) the Company's next Annual Meeting of Stockholders or (ii) May 14, 2027. |